44 results
Page 2 of 3
6-K
EX-1.1
qs1pelxbzntt3f6s
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
F-1/A
EX-4.4
ezpy701q
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
EX-1.1
qduv 98iwm965d4bn
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
EX-4.6
8hh3 evgtp5ftw
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
EX-1.1
blcuhk
9 Oct 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.3
u47292vpk2kal5
1 Jul 20
Report of Foreign Private Issuer
9:05am
F-1/A
EX-4.7
56ez3cdn
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
EX-4.7
kys60mj
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
EX-4.7
g5anwdxk
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
424B5
t9fxsvn7t
5 Dec 19
Prospectus supplement for primary offering
5:29pm
424B5
06poclx3
1 Apr 19
Prospectus supplement for primary offering
6:57am
6-K
EX-10.1
rqyl2
28 Mar 19
Therapix Biosciences Announces Pricing
8:51am
6-K
EX-99.1
42fwu3k1bg7cgtbi
28 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
6:27am
6-K
EX-10.1
2d5a 054vnyfr7ro
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
6-K
EX-10.3
obmw g7iu3oa5i
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
424B2
39v8qe19
9 Aug 18
Prospectus for primary offering
11:19am
F-3/A
ex9 iql48nv
17 Jul 18
Shelf registration (foreign) (amended)
1:29pm